**Core Concept**
Inflammatory bowel disease (IBD) encompasses a spectrum of chronic gastrointestinal disorders characterized by immune-mediated inflammation of the gut mucosa. Dermatological manifestations of IBD are a result of systemic inflammation and immune dysregulation, leading to various skin-related symptoms.

**Why the Correct Answer is Right**
The most common dermatological manifestation of IBD is erythema nodosum (EN), which is a type of skin inflammation that presents as tender, subcutaneous nodules, typically on the lower extremities. EN is thought to result from the deposition of immune complexes in the skin, triggered by the systemic inflammation associated with IBD. Additionally, pyoderma gangrenosum (PG) and Sweet's syndrome are other notable dermatological manifestations of IBD, although less common.

**Why Each Wrong Option is Incorrect**
**Option A:** Pityriasis rosea, a self-limiting skin rash, is not typically associated with IBD. It is more commonly linked to viral infections.
**Option B:** Erythema multiforme, a skin condition characterized by target lesions, can be triggered by various factors, including infections and medications, but is not a specific manifestation of IBD.
**Option C:** Psoriasis, a chronic skin condition characterized by thickened, scaly plaques, is an autoimmune disease but is distinct from IBD and not a direct manifestation of it.

**Clinical Pearl / High-Yield Fact**
When evaluating a patient with IBD, consider the possibility of dermatological manifestations, including erythema nodosum, pyoderma gangrenosum, and Sweet's syndrome, as these can be important indicators of disease severity and activity.

**Correct Answer: D. Erythema nodosum.**